Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of IV Danirixin in Healthy Adults
NCT02169583Phase 1Completed
- Sponsor
- GSK
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of danirixin in viral respiratory tract infections (2 arms), sponsored by GSK. Primary endpoints: Number of subjects with adverse events, Changes over time in clinical laboratory evaluations and 4 more. Started Jun 2014; status: completed.
02
Drugs
danirixin
03
Conditions
viral respiratory tract infections
Beyond the preview
Go deeper on NCT02169583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169583.